SAGE Therapeutics (SAGE) – Hot FDA News
-
Sage, Biogen receive setback despite FDA approval of postpartum depression drug. This is why
-
SAGE Therapeutics (SAGE), Biogen (BIIB) ZURZUVAETM approved in PPD, receives CRL for MDD
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SAGE Stock Lookup